Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...
4 天on MSN
Army bomb disposal veterans may have a significantly increased risk of developing bladder cancer compared to the general ...
Bladder cancer spreads at different speeds depending on the type of bladder cancer you have. Urothelial bladder cancer is slow to spread, while other types are much faster. Urothelial bladder ...
Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...
In March 2025, Merck Sharp & Dohme LLC announced a study are to learn if people who receive V940 and pembrolizumab are alive ...
The Independent on MSN6 天
Bomb disposal veterans face higher bladder cancer risk, study suggestsThe findings in a small study is ‘significant enough to warrant urgent further investigation’, researchers said.
There are several different treatment options available for bladder cancer. One of these is immunotherapy, a type of treatment that works to boost your immune system’s response to the cancer.
1 天
TipRanks on MSNCG Oncology Advances in Bladder Cancer TherapeuticsCG Oncology, Inc. ( ($CGON) ) has released its Q4 earnings. Here is a breakdown of the information CG Oncology, Inc. presented to its investors.
The first barrier Grivas notes is limited infusion room capacity and the need for rapid chair turnover. Other external barriers for patients include transportation and lodging. Grivas highlights that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果